Mirabegron 50 mg vs. mirabegron 100 mg vs. tolterodine 4 mg in reducing nocturia and urgency episodes in patients with Overactive Bladder/storage LUTS: a systematic review and meta-analysis

Gacci M1, Sebastianelli A1, Russo G I2, Cimino S2, Salvi M1, Spatafora P1, Carini M1, Serni S1, Moncada I3, Gravas S4, Giuliano F5, Morgia G2

Research Type


Abstract Category

Overactive Bladder

Abstract 659
Open Discussion ePosters 3
Scientific Open Discussion ePoster Session 35
Friday 15th September 2017
13:30 - 13:35 (ePoster Station 8)
Exhibition Hall
Overactive Bladder Nocturia Pharmacology Urgency Urinary Incontinence
1. Department of Urology, Careggi Hospital, University of Florence (Italy), 2. Department of Urology, Policlinico Hospital, University of Catania, Catania, Italy, 3. Department of Urology, Hospital La Zarzuela, Madrid, Spain, 4. Department of Urology, University Hospital of Larissa, Larissa, Greece, 5. AP-HP, Neuro-Uro-Andrology, Versailles Saint Quentin en Yvelines University, Versailles, France

Arcangelo Sebastianelli